You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CCCC Award Disclosure
Grogan Donna Roy · SEC Form 4 · Filed Oct 2, 2026
Award
Calculated transaction value
$14.5K
Grogan Donna Roy Director
CCCC
C4 Therapeutics
CCCC
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
CCCC daily price context
Close on/before transaction
$3.14
Oct 1, 2026
First close after public filing
$2.99
Oct 5, 2026
30-day return after filing
+7.36%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,618 shares @ $3.14
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001470831-26-000924
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$14.5K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| C4 Therapeutics, Inc. CCCC Current | Award | Oct 1, 2026 | $14.5K |